Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Melms, Johannes C. [VerfasserIn]   i
 Vallabhaneni, Sreeram [VerfasserIn]   i
 Mills, Caitlin E. [VerfasserIn]   i
 Yapp, Clarence [VerfasserIn]   i
 Chen, Jia-Yun [VerfasserIn]   i
 Morelli, Eugenio [VerfasserIn]   i
 Waszyk, Patricia [VerfasserIn]   i
 Kumar, Sushil [VerfasserIn]   i
 Deming, Derrick [VerfasserIn]   i
 Moret, Nienke [VerfasserIn]   i
 Rodriguez, Steven [VerfasserIn]   i
 Subramanian, Kartik [VerfasserIn]   i
 Rogava, Meri [VerfasserIn]   i
 Cartwright, Adam N. R. [VerfasserIn]   i
 Luoma, Adrienne [VerfasserIn]   i
 Mei, Shaolin [VerfasserIn]   i
 Brinker, Titus Josef [VerfasserIn]   i
 Miller, David M. [VerfasserIn]   i
 Spektor, Alexander [VerfasserIn]   i
 Schadendorf, Dirk [VerfasserIn]   i
 Riggi, Nicolo [VerfasserIn]   i
 Wucherpfennig, Kai W. [VerfasserIn]   i
 Sorger, Peter K. [VerfasserIn]   i
 Izar, Benjamin [VerfasserIn]   i
Titel:Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity
Verf.angabe:Johannes C. Melms, Sreeram Vallabhaneni, Caitlin E. Mills, Clarence Yapp, Jia-Yun Chen, Eugenio Morelli, Patricia Waszyk, Sushil Kumar, Derrick Deming, Nienke Moret, Steven Rodriguez, Kartik Subramanian, Meri Rogava, Adam N. R. Cartwright, Adrienne Luoma, Shaolin Mei, Titus J. Brinker, David M. Miller, Alexander Spektor, Dirk Schadendorf, Nicolo Riggi, Kai W. Wucherpfennig, Peter K. Sorger, and Benjamin Izar
E-Jahr:2020
Jahr:February 2020
Jahr des Originals:2019
Umfang:13 S.
Illustrationen:Illustrationen
Fussnoten:Published onlinefirst December 27, 2019 ; Gesehen am 02.04.2020
Titel Quelle:Enthalten in: Cancer research
Ort Quelle:Philadelphia, Pa. : AACR, 1916
Jahr Quelle:2020
Band/Heft Quelle:80(2020), 4, Seite 798-810
ISSN Quelle:1538-7445
Abstract:Patients with melanoma resistant to RAF/MEK inhibitors (RMi) are frequently resistant to other therapies, such as immune checkpoint inhibitors (ICI), and individuals succumb to their disease. New drugs that control tumor growth and favorably modulate the immune environment are therefore needed. We report that the small-molecule CX-6258 has potent activity against both RMi-sensitive (RMS) and -resistant (RMR) melanoma cell lines. Haspin kinase (HASPIN) was identified as a target of CX-6258. HASPIN inhibition resulted in reduced proliferation, frequent formation of micronuclei, recruitment of cGAS, and activation of the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway. In murine models, CX-6258 induced a potent cGAS-dependent type-I IFN response in tumor cells, increased IFNγ-producing CD8+ T cells, and reduced Treg frequency in vivo. HASPIN was more strongly expressed in malignant compared with healthy tissue and its inhibition by CX-6258 had minimal toxicity in ex vivo-expanded human tumor-infiltrating lymphocytes (TIL), proliferating TILs, and in vitro differentiated neurons, suggesting a potential therapeutic index for anticancer therapy. Furthermore, the activity of CX-6258 was validated in several Ewing sarcoma and multiple myeloma cell lines. Thus, HASPIN inhibition may overcome drug resistance in melanoma, modulate the immune environment, and target a vulnerability in different cancer lineages. - Significance: HASPIN inhibition by CX-6258 is a novel and potent strategy for RAF/MEK inhibitor-resistant melanoma and potentially other tumor types. HASPIN inhibition has direct antitumor activity and induces a favorable immune microenvironment.
DOI:doi:10.1158/0008-5472.CAN-19-2330
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: https://doi.org/10.1158/0008-5472.CAN-19-2330
 Volltext: https://cancerres.aacrjournals.org/content/80/4/798
 DOI: https://doi.org/10.1158/0008-5472.CAN-19-2330
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:169381806X
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68560602   QR-Code
zum Seitenanfang